Annals of internal medicine
-
Comment
The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at ≥14 d.
Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26. ⋯ S vaccine against Covid-19. N Engl J Med. 2021. [Epub ahead of print.] 33882225.